Finance

Beta
Lists
SVA:TSE
Sernova Biotherapeutics Inc
CA$0.15
-3.23%
(-0.0050) 1D
Jun 5, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Open
CA$0.15
High
CA$0.16
Low
CA$0.15
Mkt. cap
54.88M
Avg. vol.
124.81K
Volume
104.86K
52-wk high
CA$0.21
52-wk low
CA$0.12
EPS
-CA$0.04
Beta
30.45
Shares outstanding
347.73M
No. of employees
8
Open
CA$0.15
High
CA$0.16
Low
CA$0.15
Mkt. cap
54.88M
Avg. vol.
124.81K
Volume
104.86K
52-wk high
CA$0.21
52-wk low
CA$0.12
EPS
-CA$0.04
Beta
30.45
Shares outstanding
347.73M
No. of employees
8
News stories
From sources across the web
About Sernova Biotherapeutics Inc
CEOJonathan Rigby
Employees8
Founded2006
HeadquartersLondon, Ontario, Canada
SectorBiotechnology
Websitesernova.com
Last report
Mar 13, 2026
Fiscal period
Q1 2026
EPS / Est. (CAD)
-CA$0.01 / -CA$0.01
0.00%miss
Revenue / Est. (CAD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.36M
1.74M
809.63K
434.15K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.96M
1.76M
1.59M
1.68M
Operating expense
4.33M
3.50M
2.40M
2.12M
Total operating expenses
4.33M
3.50M
2.40M
2.12M
Operating income
-4.33M
-3.50M
-2.40M
-2.12M
Other non operating income
-
-
-
-
EBT including unusual items
-3.74M
-4.05M
-2.25M
-2.41M
EBT excluding unusual items
-3.74M
-4.10M
-2.26M
-2.41M
Income tax expense
36.88K
21.12K
-54.97K
-72.00K
Effective tax rate
-0.99%
-0.52%
2.44%
2.99%
Other operating expenses
-
-
-
-
Net income
-3.78M
-4.07M
-2.20M
-2.33M
Net profit margin
-
-
-
-
Earnings per share
-0.01
-0.01
-0.01
-0.01
Interest and investment income
2.03K
131.00
260.60K
-
Interest expense
-238.73K
-541.68K
-
-477.12K
Net interest expenses
-236.70K
-541.54K
260.60K
-477.12K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.28M
-3.40M
-2.34M
-2.11M
Gain or loss from assets sale
-
-50.96K
-4.25K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer